Founder of Pharmacolog in 2007, previous CEO and board member since 2016. Hans earned a degree in Radiation Physics at Uppsala University and have since had a long career working with cancer care problems. First as a certified Radiation Physicist at Uppsala University Hospital and R&D manager in Computational Physics in the 1970s. As part of his R&D work at Uppsala University he founded Helax, of which he became the CEO and a board member.
Independence: Not independent in relation to the Company and the Executive Management and, being a major shareholder, not independent in relation to major shareholders
Other board assignments: Deputy board member Bostadsrättsföreningen Metropolen, Board member Helax Medical AB.
Holdings: 294 043 shares (69 620 direct and 224 423 indirect) and 50 000 warrants.